BeiGene (BGNE)
(Delayed Data from NSDQ)
$148.56 USD
+4.44 (3.08%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $148.66 +0.10 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-2.58 | 0.00% |
Earnings Summary
For their last quarter, BeiGene (BGNE) reported earnings of -$3.53 per share, missing the Zacks Consensus Estimate of -$2.36 per share. This reflects a negative earnings surprise of 49.58%. Look out for BGNE's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$2.58 per share, reflecting a year-over-year increase of 22.75%.
Earnings History
Price & Consensus
Zacks News for BGNE
3 Top Biotech Stocks Worth Adding to Your Portfolio in 2024
BGNE: What are Zacks experts saying now?
Zacks Private Portfolio Services